Agilent Technologies, Inc. (NYSE:A) Shares Bought by Fuller & Thaler Asset Management Inc.

Fuller & Thaler Asset Management Inc. boosted its holdings in shares of Agilent Technologies, Inc. (NYSE:A - Free Report) by 76.6% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 10,902 shares of the medical research company's stock after buying an additional 4,727 shares during the period. Fuller & Thaler Asset Management Inc.'s holdings in Agilent Technologies were worth $1,465,000 as of its most recent SEC filing.

A number of other hedge funds have also added to or reduced their stakes in A. CKW Financial Group boosted its stake in shares of Agilent Technologies by 114.9% in the 4th quarter. CKW Financial Group now owns 187 shares of the medical research company's stock worth $25,000 after buying an additional 100 shares during the last quarter. Global X Japan Co. Ltd. raised its holdings in Agilent Technologies by 161.1% during the 4th quarter. Global X Japan Co. Ltd. now owns 188 shares of the medical research company's stock valued at $25,000 after acquiring an additional 116 shares during the period. Redwood Park Advisors LLC purchased a new stake in Agilent Technologies during the 4th quarter worth about $27,000. Lee Danner & Bass Inc. purchased a new stake in shares of Agilent Technologies in the fourth quarter worth about $29,000. Finally, Hanson & Doremus Investment Management lifted its stake in Agilent Technologies by 66.5% in the 4th quarter. Hanson & Doremus Investment Management now owns 263 shares of the medical research company's stock worth $35,000 after purchasing an additional 105 shares in the last quarter. Institutional investors and hedge funds own 87.42% of the company's stock.

Wall Street Analyst Weigh In

A has been the subject of a number of research analyst reports. Wells Fargo & Company dropped their price target on Agilent Technologies from $155.00 to $135.00 and set an "overweight" rating for the company in a research report on Thursday, April 17th. Jefferies Financial Group reduced their price objective on Agilent Technologies from $135.00 to $116.00 and set a "hold" rating on the stock in a research note on Monday, April 21st. Barclays decreased their target price on shares of Agilent Technologies from $138.00 to $115.00 and set an "equal weight" rating on the stock in a research note on Thursday, April 10th. Robert W. Baird lowered their price target on Agilent Technologies from $161.00 to $159.00 and set an "outperform" rating for the company in a research report on Thursday, February 27th. Finally, TD Cowen raised their target price on shares of Agilent Technologies to $135.00 and gave the stock a "buy" rating in a research report on Thursday, April 10th. Seven investment analysts have rated the stock with a hold rating and seven have issued a buy rating to the company. According to MarketBeat, Agilent Technologies currently has a consensus rating of "Moderate Buy" and an average price target of $143.00.

Agilent Technologies Price Performance

NYSE:A traded up $0.59 during trading hours on Tuesday, hitting $107.46. 1,201,767 shares of the stock traded hands, compared to its average volume of 1,871,450. The company has a quick ratio of 1.66, a current ratio of 2.20 and a debt-to-equity ratio of 0.56. Agilent Technologies, Inc. has a 1 year low of $96.43 and a 1 year high of $155.35. The stock has a 50 day moving average price of $115.80 and a 200 day moving average price of $130.66. The company has a market cap of $30.64 billion, a price-to-earnings ratio of 24.70, a price-to-earnings-growth ratio of 3.00 and a beta of 1.19.

Agilent Technologies (NYSE:A - Get Free Report) last released its quarterly earnings data on Wednesday, February 26th. The medical research company reported $1.31 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.27 by $0.04. The firm had revenue of $1.68 billion for the quarter, compared to analysts' expectations of $1.67 billion. Agilent Technologies had a net margin of 19.27% and a return on equity of 25.56%. Sell-side analysts forecast that Agilent Technologies, Inc. will post 5.54 EPS for the current fiscal year.

Agilent Technologies Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Wednesday, April 23rd. Shareholders of record on Tuesday, April 1st were issued a dividend of $0.248 per share. This represents a $0.99 annualized dividend and a yield of 0.92%. The ex-dividend date of this dividend was Tuesday, April 1st. Agilent Technologies's dividend payout ratio is presently 22.76%.

Insider Activity at Agilent Technologies

In other Agilent Technologies news, VP Rodney Gonsalves sold 1,908 shares of the firm's stock in a transaction dated Monday, March 17th. The shares were sold at an average price of $121.98, for a total value of $232,737.84. Following the completion of the sale, the vice president now owns 21,786 shares of the company's stock, valued at $2,657,456.28. This trade represents a 8.05 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Daniel K. Podolsky sold 1,819 shares of the business's stock in a transaction on Monday, March 31st. The shares were sold at an average price of $116.46, for a total value of $211,840.74. Following the transaction, the director now owns 35,737 shares of the company's stock, valued at approximately $4,161,931.02. The trade was a 4.84 % decrease in their position. The disclosure for this sale can be found here. 0.26% of the stock is currently owned by insiders.

Agilent Technologies Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.